Xtant Medical to Announce Second Quarter 2025 Financial Results on August 12, 2025
Xtant Medical Holdings (NYSE American: XTNT), a global medical technology company specializing in surgical solutions for spinal, orthopedic, and woundcare disorders, has scheduled its second quarter 2025 financial results announcement for August 12, 2025, before market open.
The company will host a conference call at 8:30 AM ET on the same day, featuring President and CEO Sean Browne and CFO Scott Neils. Investors can access the call through domestic (877-545-0523) and international (973-528-0016) dial-in numbers using passcode 482755. A webcast will be available, with a replay accessible on the company's website after the live call.
Xtant Medical Holdings (NYSE American: XTNT), azienda globale nel settore della tecnologia medica specializzata in soluzioni chirurgiche per disturbi spinali, ortopedici e della cura delle ferite, ha programmato l'annuncio dei risultati finanziari del secondo trimestre 2025 per il 12 agosto 2025, prima dell'apertura dei mercati.
La societ脿 terr脿 una conference call alle 8:30 AM ET dello stesso giorno, con la partecipazione del Presidente e CEO Sean Browne e del CFO Scott Neils. Gli investitori potranno accedere alla chiamata tramite i numeri nazionali (877-545-0523) e internazionali (973-528-0016) utilizzando il codice d'accesso 482755. Sar脿 disponibile una trasmissione in webcast, con la possibilit脿 di riascoltare la registrazione sul sito web aziendale dopo la diretta.
Xtant Medical Holdings (NYSE American: XTNT), una empresa global de tecnolog铆a m茅dica especializada en soluciones quir煤rgicas para trastornos espinales, ortop茅dicos y de cuidado de heridas, ha programado el anuncio de resultados financieros del segundo trimestre de 2025 para el 12 de agosto de 2025, antes de la apertura del mercado.
La compa帽铆a llevar谩 a cabo una llamada conferencia a las 8:30 AM ET del mismo d铆a, con la participaci贸n del Presidente y CEO Sean Browne y del CFO Scott Neils. Los inversores podr谩n acceder a la llamada mediante los n煤meros nacionales (877-545-0523) e internacionales (973-528-0016) utilizando el c贸digo de acceso 482755. Habr谩 una transmisi贸n en webcast disponible, con la opci贸n de reproducir la grabaci贸n en el sitio web de la compa帽铆a despu茅s de la llamada en vivo.
Xtant Medical Holdings (NYSE American: XTNT)電� 觳欖稊, 鞝曧槙鞕戈臣 氚� 靸侅矘 旃橂 歆堩櫂鞚� 鞙勴暅 靾橃垹 靻旊（靺橃潉 鞝勲鞙茧 頃橂姅 旮�搿滊矊 鞚橂 旮办垹 須岇偓搿�, 2025雲� 8鞗� 12鞚� 2攵勱赴 2025雲� 鞛 鞁れ爜 氚滍憸毳� 鞁滌灔 臧滌灔 鞝�鞐� 鞓堨爼頄堨姷雼堧嫟.
須岇偓電� 臧欖潃 雮� 霃欕秬 鞁滉皠 鞓れ爠 8鞁� 30攵�鞐� Sean Browne 靷灔 瓴� CEO鞕� Scott Neils CFO臧� 彀胳棳頃橂姅 旎嵓霟办姢 旖滌潉 臧滌禍頃╇媹雼�. 韴瀽鞛愲摛鞚� 甑偞 鞝勴檾氩堩樃(877-545-0523) 氚� 甑牅 鞝勴檾氩堩樃(973-528-0016)毳� 韱淀暣 鞝戩啀 旖旊摐 482755毳� 靷毄頃橃棳 旖滌棎 彀胳棳頃� 靾� 鞛堨姷雼堧嫟. 鞗轨簮鞀ろ姼霃� 鞝滉车霅橂┌, 靸濎瓿� 頉� 須岇偓 鞗轨偓鞚错姼鞐愳劀 雼れ嫓 霌ｊ赴臧� 臧�電ロ暕雼堧嫟.
Xtant Medical Holdings (NYSE American : XTNT), une entreprise mondiale de technologie m茅dicale sp茅cialis茅e dans les solutions chirurgicales pour les troubles de la colonne vert茅brale, orthop茅diques et des soins des plaies, a programm茅 l'annonce des r茅sultats financiers du deuxi猫me trimestre 2025 pour le 12 ao没t 2025, avant l'ouverture du march茅.
L'entreprise tiendra une conf茅rence t茅l茅phonique 脿 8h30 ET le m锚me jour, anim茅e par le pr茅sident-directeur g茅n茅ral Sean Browne et le directeur financier Scott Neils. Les investisseurs pourront acc茅der 脿 l'appel via les num茅ros nationaux (877-545-0523) et internationaux (973-528-0016) en utilisant le code d'acc猫s 482755. Un webcast sera disponible, avec une rediffusion accessible sur le site Web de l'entreprise apr猫s l'appel en direct.
Xtant Medical Holdings (NYSE American: XTNT), ein globales Medizintechnikunternehmen, das sich auf chirurgische L枚sungen f眉r Wirbels盲ulen-, orthop盲dische und Wundversorgungsst枚rungen spezialisiert hat, hat die Ver枚ffentlichung der Finanzergebnisse f眉r das zweite Quartal 2025 am 12. August 2025 vor B枚rsen枚ffnung geplant.
Das Unternehmen wird am selben Tag um 8:30 Uhr ET eine Telefonkonferenz abhalten, an der Pr盲sident und CEO Sean Browne sowie CFO Scott Neils teilnehmen werden. Investoren k枚nnen 眉ber nationale (877-545-0523) und internationale (973-528-0016) Einwahlnummern mit dem Zugangscode 482755 an der Konferenz teilnehmen. Ein Webcast wird verf眉gbar sein, und eine Aufzeichnung wird nach dem Live-Anruf auf der Website des Unternehmens abrufbar sein.
- None.
- None.
叠贰尝骋搁础顿贰,听惭辞苍迟., Aug. 5, 2025 /PRNewswire/ -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal, orthopedic, and woundcare disorders, today announced that it will release its financial results for the second quarter ended June 30, 2025, before the start of trading on Tuesday, August 12, 2025.
Sean Browne, President and Chief Executive Officer, and Scott Neils, Chief Financial officer, will host a conference call at 8:30am ET on that day.
Conference Details:
Conference Date: Tuesday, August 12, 2025
Conference Time: 8:30 AM ET
ConferenceDial-in: 877-545-0523
International Dial-in: 973-528-0016
Passcode: 482755
Conference Call Name: Xtant Medical Q2 2025 Financial Results
Webcast link:
Following the live call, a replay will be available on the Company's website,聽, under "Investor info."
About聽Xtant Medical Holdings, Inc.
Xtant Medical's mission of honoring the gift of donation so that our patients can live as full and complete a life as possible, is the driving force behind our company. Xtant Medical Holdings, Inc. () is a global medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics serving the chronic and surgical wound care and sports medicine markets, as well as spinal implant systems. Xtant people are dedicated and talented, operating with the highest integrity to serve our customers.
The symbols 鈩� and 庐 denote trademarks and registered trademarks of Xtant Medical Holdings, Inc. or its affiliates, registered as indicated in
View original content to download multimedia:
SOURCE Xtant Medical Holdings, Inc.
FAQ
When will Xtant Medical (XTNT) release Q2 2025 earnings?
How can investors access Xtant Medical's Q2 2025 earnings call?
Who will present during Xtant Medical's Q2 2025 earnings call?
Where can I find the replay of Xtant Medical's Q2 2025 earnings call?
